Micronutrient (MN) deficiencies are highly prevalent in India, particularly among women of reproductive age (WRA) and preschool aged children (PSC). MN fortification of a staple food or condiment can be an effective strategy for improving the MN status of nutritionally vulnerable populations, as the approach is cost-effective, utilizes existing delivery systems, can deliver multiple MNs simultaneously, and does not require behavior change by the population. Salt is a particularly attractive vehicle for multiple MN fortification in India, as it is universally consumed in fairly consistent amounts; and 93% of households already use adequately iodized salt. The overall goal of this study is to evaluate the nutritional impact of quintuply-fortified salt with iron in the form of FePP (FePP-Q5S, i.e. salt fortified with iron in the form of ferric pyrophosphate plus ethylenediaminetetraacetic acid as an enhancer of absorption; zinc in the form of zinc oxide; vitamin B12; folic acid; and iodine) vs. quintuply-fortified salt with iron in the form of eFF (eFF-Q5S i.e. salt fortified with iron in the form of encapsulated ferrous fumarate; zinc in the form of zinc oxide, vitamin B12, folic acid, and iodine) vs. iodized salt (IS) for the improvement of micronutrient status among nonpregnant WRA and preschool-aged children (12-59 months of age) in Punjab, India. Enrolled women (and their affiliated households) will be randomized to receive 1 kg of their assigned study salt per month for 12 months, and will be instructed to use the study salt in place of their usual salt. Blood and urine samples will be collected from participant WRA and PSC at enrollment, 6 months and at the end of the 12-month intervention period. The change in the mean concentration of various MN biomarkers will be considered primary outcomes. Stool samples will also be collected from a subgroup of women and children to assess changes in the gut microbiome over the intervention period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
1,389
Salt fortified with iron, zinc, vitamin B12, folic acid, and iodine
Salt fortified with iodine
Postgraduate Institute of Medical Education and Research, Chandigarh
Chandigarh, India
Change in serum ferritin
Change in inflammation-adjusted mean serum ferritin concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in hemoglobin
Change in mean hemoglobin concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in soluble transferrin
Change in inflammation-adjusted mean soluble transferrin concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in red blood cell folate
Change in mean red blood cell folate concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in plasma zinc
Change in mean plasma zinc concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in serum vitamin B12
Change in mean serum vitamin B12 concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in holo-transcobalamin
Change in mean holo-transcobalamin concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in methylmalonic acid
Change in mean concentration of methylmalonic acid
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in serum folate
Change in mean serum folate concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in urinary iodine
Change in mean urinary iodine concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in serum thyroglobulin
Change in mean serum thyroglobulin concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in nail zinc
Change in mean fingernail zinc concentration
Time frame: Enrollment to 12 months (i.e. end of intervention period)
Change in gut microbiota
Change in the abundance of potentially beneficial microbiota in the gut
Time frame: Enrollment to 12 months (i.e. end of intervention period)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.